## **Core Concept**
Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare, acquired, life-threatening disease of the blood characterized by the destruction of red blood cells (hemolysis), bone marrow failure, and the presence of blood clots. It is associated with a deficiency of specific proteins on the surface of blood cells.

## **Why the Correct Answer is Right**
The correct answer, **GPI anchor (Glycosylphosphatidylinositol)**, is related to the pathophysiology of PNH. PNH is caused by a mutation in the **PIGA (phosphatidylinositol glycan class A)** gene, which is necessary for the synthesis of the GPI anchor. The GPI anchor is crucial for attaching many proteins to the surface of blood cells, including **CD55 (decay-accelerating factor)** and **CD59 (membrane inhibitor of reactive lysis)**. These proteins protect red blood cells from complement-mediated lysis. Without the GPI anchor, these protective proteins are not present on the surface of PNH cells, making them susceptible to complement-mediated destruction.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While specific proteins like CD55 and CD59 are deficient in PNH, stating them as the cause is not as accurate as identifying the root cause, which is the deficiency of the GPI anchor.
- **Option B:** This option is incorrect because it is not specified and does not directly relate to the known pathophysiology of PNH.
- **Option C:** This option is incorrect because, although complement regulatory proteins are involved, the primary issue in PNH is the deficiency of the GPI anchor, not the complement system itself.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that PNH patients often present with **intravascular hemolysis**, **thrombosis**, and **bone marrow failure**. The diagnosis of PNH can be confirmed by **flow cytometry** demonstrating a deficiency of GPI-anchored proteins on the surface of blood cells.

## **Correct Answer:** . GPI anchor.